TMC125: new results, large phase III trial begins.
New data, new trials on "2nd generation" experimental NNRTI much less subject to viral resistance than efavirenz or nevirapine.
James
John S
JS
D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019562:Viral Load
D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine